Illumina Ventures

Activity in this selectionegb-capital-4a5e7f8d

By stage

Series A1

Series B1

Undisclosed1

Biotech3

United States2

United Kingdom1

3 in this selection

Jun 21

Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine

$14.4MSeries A+

Role not disclosed

Jun 10

Develops ultrasound-mediated nonviral genetic medicines

$125MSeries B

Role not disclosed

Apr 14

Develops functional single-cell analysis tools and platforms for life science research

$27MUndisclosed

Role not disclosed